Get started
XBiotech Inc.XBiotech Inc.XBiotech Inc.

XBiotech Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

XBIT chart


Full chart

XBIT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪197.84 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.07 USD
Net income (FY)
‪−24.56 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪19.77 M‬
Beta (1Y)
1.41

Employees


Employees (FY)
82
Change (1Y)
−3 −3.53%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−299.48 K‬ USD

About XBiotech Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
John Simard
Website
xbiotech.com
Headquarters
Austin
Founded
2005
FIGI
BBG0081S8D39
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

XBIT news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of XBIT is 6.49 USD — it has decreased by −2.70% in the past 24 hours. Watch XBiotech Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange XBiotech Inc. stocks are traded under the ticker XBIT.
XBIT stock has fallen by −8.46% compared to the previous week, the month change is a −13.24% fall, over the last year XBiotech Inc. has showed a 78.30% increase.
XBIT reached its all-time high on Apr 21, 2015 with the price of 32.50 USD, and its all-time low was 2.13 USD and was reached on Sep 11, 2018. View more price dynamics on XBIT chart.
See other stocks reaching their highest and lowest prices.
XBIT stock is 7.39% volatile and has beta coefficient of 1.41. Track XBiotech Inc. stock price on the chart and check out the list of the most volatile stocks — is XBiotech Inc. there?
Today XBiotech Inc. has the market capitalization of ‪203.32 M‬, it has decreased by −6.06% over the last week.
Yes, you can track XBiotech Inc. financials in yearly and quarterly reports right on TradingView.
XBiotech Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
XBIT net income for the last quarter is ‪−5.01 M‬ USD, while the quarter before that showed ‪−13.01 M‬ USD of net income which accounts for 61.44% change. Track more XBiotech Inc. financial stats to get the full picture.
As of Nov 21, 2024, the company has 82.00 employees. See our rating of the largest employees — is XBiotech Inc. on this list?
Like other stocks, XBIT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XBiotech Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So XBiotech Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating XBiotech Inc. stock shows the sell signal. See more of XBiotech Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.